Sector
Recent investment activity
KANDO id: 274503
Corporate information
Official name
Eli Lilly & Co
Funding rounds
Investment preferences
Actual initial investment stage
Investment activity status
Active investor
Selected investments
Displaying 1 - 6 of 6| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
|
Ajax Therapeutics Inc | Blood cancer biotech. | Series C Initial investment | |||
|
Zephyr AI Inc | Precision medicine startup. | Series A Initial investment | |||
|
Mission Bay Capital III | Fund Closing | ||||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Novartis Animal Health | Acquisition Initial investment led the round USD 5,400,000,000 (USD 5,400,000,000) | ||||
|
|
Imclone Systems | Acquisition Initial investment led the round USD 7,133,620,000 (USD 7,133,620,000) | ||||
|
|
INext Fund | Fund Closing |